Novonesis (Novozymes) B (FRA:NZM) Tariff Resilience Score: 9/10 (As of Jul. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:NZM Novonesis (Novozymes) B FRA:NZM
90 GF Score
Price €55.50
GF Value €55.31
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Novonesis (Novozymes) B Tariff Resilience Score?

Novonesis (Novozymes) B FRA:NZM -0.89% 90 Tariff Resilience Score is 9 as of Jul. 17, 2026. GuruFocus rates FRA:NZM with a GF Score™ of 90/100 and a GF Value™ of €55.31 (Fairly Valued). The stock has 6 warning signs investors should review. Among 1,617 Chemicals companies, Novonesis (Novozymes) B ranks better than 99.94% on this metric.

Novonesis (Novozymes) B has the Tariff Resilience Score of 9, which implies that the company might have Highly Resilient.

Novonesis (Novozymes) B has Novozymes benefits from a global supply chain and diverse market presence. Its products often fall under tariff exemptions due to their industrial and environmental applications. The company has historically managed tariff impacts effectively through strategic sourcing.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Novonesis (Novozymes) B might have Highly Resilient.

Novonesis (Novozymes) B  (FRA:NZM) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Novonesis (Novozymes) B Tariff Resilience Score Related Terms

FRA:NZM vs LIN, SHW, ECL: Tariff Resilience Score Comparison

For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novonesis (Novozymes) B Tariff Resilience Score vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Novonesis (Novozymes) B's Tariff Resilience Score falls into.


FRA:NZM
90GF Score
Novonesis (Novozymes) B FRA:NZM
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 9 mean?
Novonesis (Novozymes) B (FRA:NZM) has a Tariff Resilience Score of 9 as of Jul. 17, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Novonesis (Novozymes) B ranks #1 out of 1617 companies in the Chemicals industry, placing it in the top 0.099999999999994%.
Is Novonesis (Novozymes) B's Tariff Resilience Score too high?
Novonesis (Novozymes) B's current Tariff Resilience Score is 9. Based on the distribution chart, Novonesis (Novozymes) B ranks #1 out of 1617 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Novonesis (Novozymes) B has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Novonesis (Novozymes) B's Tariff Resilience Score compare to LIN and SHW?
According to the Chemicals industry distribution chart, Novonesis (Novozymes) B ranks #1 out of 1617 companies for Tariff Resilience Score. This places Novonesis (Novozymes) B in the top 0% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Chemicals company?
A good Tariff Resilience Score depends on the Chemicals industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Novonesis (Novozymes) B's current Tariff Resilience Score is 9. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novonesis (Novozymes) B stock overvalued right now?
Based on GuruFocus' analysis, Novonesis (Novozymes) B (FRA:NZM) is currently considered Fairly Valued. The stock's GF Value™ is €55.31, compared to a current price of €55.50 — trading 0.3% above its estimated fair value. The current Tariff Resilience Score is 9. Novonesis (Novozymes) B's overall GF Score™ is 90/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Novonesis (Novozymes) B (FRA:NZM), the current Tariff Resilience Score is 9 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Novonesis (Novozymes) B (FRA:NZM) Overvalued in 2026?

Based on GuruFocus' analysis, Novonesis (Novozymes) B stock appears to be overvalued. The current stock price of €55.50 is trading 0.3% above its estimated GF Value™ of €55.31. GuruFocus considers Novonesis (Novozymes) B to be Fairly Valued.

Key valuation signals for FRA:NZM:

  • Tariff Resilience Score: 9
  • GF Value™: €55.31 vs. price of €55.50 (0.3% above fair value)
  • GF Score™: 90/100 with 6 warning signs

No single metric tells the full story. See the FRA:NZM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Novonesis (Novozymes) B Business Description

Address Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs more than 11,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.
90GF Score

Get the complete analysis for FRA:NZM

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€55.50
Price
€55.31
GF Value